Back to Authors

Chakraborty, Rajshekhar

0000-0001-7336-3003

Mayo Clinic

Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York, USA.

Citations 25

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma
Chakraborty, Rajshekhar , Muchtar, Eli , Kumar, Shaji , Dingli, David , Dispenzieri, Angela , Hayman, Suzanne R. , Kapoor, Prashant , Lacy, Martha Q. , Buadi, Francis K. , Hogan, William J. , Leung, Nelson , Gertz, Morie A. , Muchtar, E , Dispenzieri, Angela , Chakraborty, Rajshekhar , Dingli, David

Leukemia & Lymphoma | July 8, 2016 | Volume: 58 | Issue: 2 | Pages: 308-315

10.1080/10428194.2016.1201572 Get It

First report of MYD88L265P somatic mutation in IgM-associated light-chain amyloidosis
Chakraborty, Rajshekhar , Novak, Anne J. , Ansell, Stephen M. , Muchtar, Eli , Kapoor, Prashant , Hayman, Suzanne R. , Lacy, Martha Q. , King, Rebecca L. , Buadi, Francis K. , Dispenzieri, Angela , Gertz, Morie A. , Muchtar, E , Chakraborty, Rajshekhar

Blood | April 1, 2016 | Volume: 127 | Issue: 23 | Pages: 2936-2938

10.1182/blood-2016-02-702035 Get It

Lymphoplasmacytic lymphoma: What we need to know
Chakraborty, Rajshekhar , Chakraborty, Rajshekar, Gertz, Morie A. , Chakraborty, Rajshekhar

Leukemia & Lymphoma | September 16, 2015 | Volume: 57 | Issue: 5 | Pages: 991-992

10.3109/10428194.2015.1092531 Get It

A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties
Chakraborty, Rajshekhar , Litzow, Mark R. , Mohty, Mohamad , Hashmi, Shahrukh K. , Hashmi, Shahrukh, Savani, Bipin N. , Litzow, Mark R. , Chakraborty, Rajshekhar , Mohty, Mohamad

Cancer | April 14, 2015 | Volume: 121 | Issue: 14 | Pages: 2303-2313

10.1002/cncr.29382 Get It

The widespread use of complementary and alternative medicine (CAM) in cancer survivors is well known despite a paucity of scientific evidence to support its use. The number of survivors of hematopoietic stem cell transplant (HCT) is growing rapidly and HCT clinicians are aware that many of their patients use CAM therapies consistently. However, due to a paucity of data regarding the benefits and harms of CAM therapies in these survivors, clinicians are reluctant to provide specific recommendations for or against particular CAM therapies. A systematic literature review was conducted with a search using PubMed, the Cochrane Database of Systematic Reviews, and Ovid online for each CAM therapy as defined by the National Center of Complementary and Alternative Medicine. The search generated 462 references, of which 26 articles were deemed to be relevant for the review. Due to extensive heterogeneity in data and limited randomized trials, a meta‐analysis could not be performed but a comprehensive systematic review was conducted with specified outcomes for each CAM therapy. In randomized controlled trials, certain mind and body interventions such as relaxation were observed to be effective in alleviating psychological symptoms in patients undergoing HCT, whereas the majority of the other CAM treatments were found to have mixed results. CAM use is an understudied area in HCT survivorship and clinicians should convey the benefits and uncertainties concerning the role of CAM therapies to their patients. Cancer 2015;121:2303–2313. © 2015 American Cancer Society.